Literature DB >> 9854685

Bone mineral density and circulating cytokines in patients with acromegaly.

S Longobardi1, C Di Somma, F Di Rella, N Angelillo, D Ferone, A Colao, B Merola, G Lombardi.   

Abstract

Acromegalic patients present an increase of osteoblastic and osteoclastic activity, showing a different effect on the axial and appendicular skeletal structures. At this regard controversial data about bone mineral density (BMD) have been published in literature. In fact an increase of BMD levels in femoral neck and Ward's triangle without any difference in lumbar spine has been described. On the other hand normal BMD levels at forearm and reduced BMD levels at lumbar spine were found. These patients seem to have a reduction of trabecular BMD similar to postmenopausal osteoporotic patients despite normal or slightly elevated cortical BMD. Recently, it has been described that cytokines, in particular tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1), are implicated in the pathogenetic mechanism of postmenopausal osteoporosis. Taking into account that growth hormone (GH) can increase TNF-alpha and IL-1 secretion by mononuclear blood cells, the evaluation of possible relationship between the reduced BMD at lumbar spine and circulating cytokines levels was carried out in acromegalic patients. In addition we evaluated the effect of acute octreotide administration on serum TNF-alpha and IL-I concentrations. Eleven patients with active acromegaly and eleven healthy age-, sex-, weight- and heightmatched subjects were enrolled in this study. BMD was significantly reduced at lumbar spine (0.80 +/- 0.29 g/cm2 vs 1.02 +/- 0.11 g/cm2; p < 0.01), but not at femoral neck level or at Ward's triangle level (0.92 + 0.15 g/cm2 vs 0.97 + 0.11 g/cm2, p = NS; and 0.74 +/- 0.16 g/cm2 vs 0.85 +/- 0.1 g/cm2, p = NS) when compared to controls. Baseline serum levels of TNF-alpha and IL-1 were in the normal range both in patients and controls. After acute octreotide administration, no differences in circulating TNF-alpha and IL-1 levels were found. In conclusion, acromegalic patients present a reduced BMD at lumbar spine but not at femoral neck level and Ward's triangle. Circulating cytokines such as TNF-alpha and IL-1 are in the normal range. These data suggest that cytokines are not involved in the pathogenesis of GH-excess induced osteoporosis. The possibility that the GH excess might affect bone turnover inducing an increase of cytokines acting by a paracrine/autocrine mechanism cannot be ruled out.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9854685     DOI: 10.1007/bf03350799

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  28 in total

1.  Skeletal dynamics in man measured by nonradioactive strontium.

Authors:  E EISENBERG; G S GORDAN
Journal:  J Clin Invest       Date:  1961-10       Impact factor: 14.808

2.  Osteopenia occurs in a minority of patients with acromegaly and is predominant in the spine.

Authors:  M J Kayath; J G Vieira
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

3.  Studies of 47Ca metabolism in acromegaly.

Authors:  N H Bell; F C Bartter
Journal:  J Clin Endocrinol Metab       Date:  1967-02       Impact factor: 5.958

4.  The nature of the metabolic bone disorder in acromegaly.

Authors:  B L Riggs; R V Randall; H W Wahner; J Jowsey; P J Kelly; M Singh
Journal:  J Clin Endocrinol Metab       Date:  1972-06       Impact factor: 5.958

5.  Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperparathyroidism and correlate with markers of bone resorption--a clinical research center study.

Authors:  A Grey; M A Mitnick; S Shapses; A Ellison; C Gundberg; K Insogna
Journal:  J Clin Endocrinol Metab       Date:  1996-10       Impact factor: 5.958

6.  Oestradiol inhibits the release of tumour necrosis factor but not interleukin 6 from adult human osteoblasts in vitro.

Authors:  D Rickard; G Russell; M Gowen
Journal:  Osteoporos Int       Date:  1992-03       Impact factor: 4.507

7.  Hypophysectomy inhibits the synthesis of tumor necrosis factor alpha by rat macrophages: partial restoration by exogenous growth hormone or interferon gamma.

Authors:  C K Edwards; R M Lorence; D M Dunham; S Arkins; L M Yunger; J A Greager; R J Walter; R Dantzer; K W Kelley
Journal:  Endocrinology       Date:  1991-02       Impact factor: 4.736

8.  Mineral and bone metabolism in thyroid disease: a review.

Authors:  J Auwerx; R Bouillon
Journal:  Q J Med       Date:  1986-08

9.  Axial and appendicular bone density predict fractures in older women.

Authors:  D M Black; S R Cummings; H K Genant; M C Nevitt; L Palermo; W Browner
Journal:  J Bone Miner Res       Date:  1992-06       Impact factor: 6.741

10.  Bone mineral changes in primary hyperparathyroidism.

Authors:  M L Richardson; R S Pozzi-Mucelli; A S Kanter; F O Kolb; B Ettinger; H K Genant
Journal:  Skeletal Radiol       Date:  1986       Impact factor: 2.199

View more
  7 in total

Review 1.  Bone mineral density in acromegaly: does growth hormone excess protect against osteoporosis?

Authors:  I Chiodini; V Trischitta; V Carnevale; A Liuzzi; A Scillitani
Journal:  J Endocrinol Invest       Date:  2001-04       Impact factor: 4.256

2.  Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function.

Authors:  Marek Bolanowski; Jacek Daroszewski; Marek Medraś; Beata Zadrozna-Sliwka
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

3.  Exon 3-deleted growth hormone receptor isoform is not related to worse bone mineral density or microarchitecture or to increased fracture risk in acromegaly.

Authors:  J Pontes; M Madeira; C H A Lima; L L Ogino; F de Paula Paranhos Neto; L M C de Mendonça; M L F Farias; L Kasuki; M R Gadelha
Journal:  J Endocrinol Invest       Date:  2019-08-07       Impact factor: 4.256

4.  Effects of GH-IGF-I excess and gonadal status on bone mineral density and body composition in patients with acromegaly.

Authors:  M Madeira; L V Neto; G A B de Lima; R O Moreira; L M C de Mendonça; M R Gadelha; M L F Farias
Journal:  Osteoporos Int       Date:  2010-03-20       Impact factor: 4.507

Review 5.  Musculoskeletal Effects of Altered GH Action.

Authors:  Jonathan A Young; Shouan Zhu; Edward O List; Silvana Duran-Ortiz; Yosri Slama; Darlene E Berryman
Journal:  Front Physiol       Date:  2022-05-19       Impact factor: 4.755

Review 6.  Growth hormone, insulin-like growth factors, and the skeleton.

Authors:  Andrea Giustina; Gherardo Mazziotti; Ernesto Canalis
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

Review 7.  Acromegaly, inflammation and cardiovascular disease: a review.

Authors:  Thalijn L C Wolters; Mihai G Netea; Niels P Riksen; Adrianus R M M Hermus; Romana T Netea-Maier
Journal:  Rev Endocr Metab Disord       Date:  2020-12       Impact factor: 6.514

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.